NBT Bank’s Thermo Fisher Scientific TMO Stock Holding History

NBT Bank’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.27M	Sell	8,521 -88	-1%	-$42.2K	0.28%	81
2026 Q1	$4.23M	Sell	8,609 -1,323	-13%	-$718K	0.28%	88
2025 Q4	$5.43M	Sell	9,932 -618	-6%	-$349K	0.35%	74
2025 Q3	$4.89M	Buy	10,550 +1,004	+11%	+$467K	0.32%	79
2025 Q2	$3.87M	Sell	9,546 -598	-6%	-$250K	0.27%	94
2025 Q1	$5.05M	Sell	10,144 -940	-8%	-$509K	0.36%	73
2024 Q4	$5.77M	Sell	11,084 -471	-4%	-$259K	0.4%	64
2024 Q3	$7.15M	Sell	11,555 -430	-4%	-$255K	0.48%	53
2024 Q2	$6.63M	Buy	11,985 +54	+0.5%	+$30.9K	0.47%	55
2024 Q1	$6.93M	Sell	11,931 -15	-0.1%	-$8.42K	0.51%	49
2023 Q4	$6.34M	Buy	11,946 +76	+0.6%	+$36.8K	0.5%	50
2023 Q3	$6.01M	Buy	11,870 +10,849	+1,063%	+$5.78M	0.58%	44
2023 Q2	$533K	Sell	1,021 -50	-5%	-$27K	0.08%	171
2023 Q1	$617K	Sell	1,071 -150	-12%	-$84.5K	0.09%	161
2022 Q4	$672K	Buy	1,221 +105	+9%	+$55.6K	0.1%	152
2022 Q3	$566K	Sell	1,116 -60	-5%	-$33.6K	0.09%	152
2022 Q2	$639K	Hold	1,176	–	–	0.1%	145
2022 Q1	$694K	Hold	1,176	–	–	0.09%	146
2021 Q4	$784K	Hold	1,176	–	–	0.1%	141
2021 Q3	$672K	Buy	1,176 +10	+0.9%	+$5.49K	0.09%	150
2021 Q2	$588K	Hold	1,166	–	–	0.08%	153
2021 Q1	$532K	Sell	1,166 -150	-11%	-$71.6K	0.08%	158
2020 Q4	$613K	Buy	1,316 +16	+1%	+$7.5K	0.09%	145
2020 Q3	$574K	Sell	1,300 -18	-1%	-$7.44K	0.1%	149
2020 Q2	$478K	Hold	1,318	–	–	0.09%	148
2020 Q1	$374K	Hold	1,318	–	–	0.08%	157
2019 Q4	$428K	Buy	+1,318	New	+$400K	0.07%	164
2017 Q2	–	Sell	-1,500	Closed	-$230K	–	209
2017 Q1	$230K	Hold	1,500	–	–	0.04%	192
2016 Q4	$212K	Hold	1,500	–	–	0.04%	194
2016 Q3	$239K	Hold	1,500	–	–	0.04%	187
2016 Q2	$222K	Sell	1,500 -287	-16%	-$42.4K	0.04%	189
2016 Q1	$253K	Hold	1,787	–	–	0.04%	177
2015 Q4	$253K	Sell	1,787 -150	-8%	-$20K	0.05%	169
2015 Q3	$237K	Hold	1,937	–	–	0.04%	175
2015 Q2	$251K	Hold	1,937	–	–	0.04%	177
2015 Q1	$260K	Hold	1,937	–	–	0.04%	180
2014 Q4	$243K	Sell	1,937 -63	-3%	-$7.66K	0.04%	183
2014 Q3	$243K	Sell	2,000 -47	-2%	-$5.71K	0.04%	183
2014 Q2	$242K	Sell	2,047 -200	-9%	-$23.5K	0.04%	188
2014 Q1	$270K	Sell	2,247 -38	-2%	-$4.52K	0.04%	186
2013 Q4	$255K	Hold	2,285	–	–	0.04%	187
2013 Q3	$210K	Buy	+2,285	New	+$207K	0.03%	198

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

NBT Bank's TMO Position: Q2 2026 in Review

NBT Bank reduced its Thermo Fisher Scientific (TMO) stake by 1% in Q2 2026, selling an estimated $42.2K and leaving 8,521 shares worth $4.27M. The position accounts for 0.28% of the portfolio, ranked #81.

NBT Bank first reported a position in TMO in Q3 2013 and has held it in 42 quarters since. The position peaked at $7.15M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

NBT Bank held 8,521 shares of Thermo Fisher Scientific worth $4.27M as of Q2 2026.
NBT Bank sold 88 Thermo Fisher Scientific shares in Q2 2026, an estimated $42.2K.
Thermo Fisher Scientific made up 0.28% of NBT Bank's portfolio in Q2 2026, its #81 holding.
NBT Bank first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 42 quarters since.
NBT Bank's Thermo Fisher Scientific position peaked at $7.15M in Q3 2024.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on NBT Bank's 13F filing for Q2 2026, filed 29 Jul 2026.